4-NITROBENZYL (R)-2-DIAZO-4-((2R,3S)-3-((R)-1-HYDROXYETHYL)-4-OXO-2-AZETIDINYL)-3-OXOPENTANOATE
UNII GEJ8U54SJZ

Substance Identification & Data

This profile provides standardized clinical and technical data for 4-nitrobenzyl (r)-2-diazo-4-((2r,3s)-3-((r)-1-hydroxyethyl)-4-oxo-2-azetidinyl)-3-oxopentanoate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) GEJ8U54SJZ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 90822-24-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
GEJ8U54SJZ
CAS Registry Number
90822-24-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
4-NITROBENZYL (R)-2-DIAZO-4-((2R,3S)-3-((R)-1-HYDROXYETHYL)-4-OXO-2-AZETIDINYL)-3-OXOPENTANOATE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C17H18N4O7
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
FDXUXRZSNNSUGD-NRMKKVEVSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
57009450
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
[C@@H](C(C(C(OCc1ccc([N+](=O)[O-])cc1)=O)=[N+]=[N-])=O)(C)[C@@]2([C@@]([C@@H](C)O)(C(=O)N2)[H])[H]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 4-nitrobenzyl (r)-2-diazo-4-((2r,3s)-3-((r)-1-hydroxyethyl)-4-oxo-2-azetidinyl)-3-oxopentanoate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

MEROPENEM IMPURITY 13

Systematic Nomenclature

(4-NITROPHENYL)METHYL (.GAMMA.R,2R,3S)-.ALPHA.-DIAZO-3-((1R)-1-HYDROXYETHYL)-.GAMMA.-METHYL-.BETA.,4-DIOXO-2-AZETIDINEBUTANOATE
(R)-4-NITROBENZYL 2-DIAZO-4-((2R,3S)-3-((R)-1-HYDROXYETHYL)-4-OXOAZETIDIN-2-YL)-3-OXOPENTANOATE
2-AZETIDINEBUTANOIC ACID, .ALPHA.-DIAZO-3-((1R)-1-HYDROXYETHYL)-.GAMMA.-METHYL-.BETA.,4-DIOXO-, (4-NITROPHENYL)METHYL ESTER, (.GAMMA.R,2R,3S)-
2-AZETIDINEBUTANOIC ACID, .ALPHA.-DIAZO-3-(1-HYDROXYETHYL)-.GAMMA.-METHYL-.BETA.,4-DIOXO-, (4-NITROPHENYL)METHYL ESTER, (2R-(2.ALPHA.(R*),3.BETA.(R*)))-
4-NITROBENZYL (R)-2-DIAZO-4-((2R,3S)-3-((R)-1-HYDROXYETHYL)-4-OXO-2-AZETIDINYL)-3-OXOPENTANOATE

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NLM
PubChem Compound